ALT 3000

Drug Profile

ALT 3000

Alternative Names: desHis(1)Neu(8)Ala(11)Ala(16) glucagon amide

Latest Information Update: 07 May 2001

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Rockefeller University
  • Class Amides; Antihyperglycaemics
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Diabetes mellitus

Most Recent Events

  • 07 May 2001 Discontinued-Preclinical for Diabetes mellitus in USA (Unknown route)
  • 03 Aug 1998 No-Development-Reported for Diabetes mellitus in USA (Unknown route)
  • 13 Aug 1996 Preclinical development for Diabetes mellitus in USA (Unknown route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top